TwoKnct Media & Publishing

Welcome to the Rare Diseases & Orphan Drugs Conference 2026

Rare Diseases & Orphan Drugs Conference

From Innovation to Access: Advancing Treatments for Rare Diseases

Join global pioneers as we connect science, policy, and partnerships — from discovery to patient access

Welcome to the Rare Diseases & Orphan Drugs Conference 2026 — Europe’s leading forum uniting researchers, biotech leaders, regulators, and patient advocates to accelerate therapies for rare and ultra-rare conditions. Join global pioneers as we connect science, policy, and partnerships — from discovery to patient access.

James D. Chambers

Director, SPEC Database Professor, Tufts University School of Medicine

Jill Goodrich

Co-Executive Director

Pedro Franco

Head of Europe Global Regulatory and Scientific Policy, Senior Director.

Kim Angel

Executive Director International MPS Network

Dr. Marco Rauland

Vice President Global Head of GVAP Strategy, Pricing & Analytics

Henriëtte Burghoorn

Associate Director, Market Access| Netherlands

Patroski J. Lawson

CEO, The KPM Group DC

Marieangela

Economopoulou PhD, MBA Head External Affairs & Patient Value Access

Arjun Channi

Director, Global Regulatory Lead (Rare Disease)

Barry Weber

CISO & DPO

Alan Minsk

Partner at Arnall Golden Gregory LLP

David Du

Sr. Manager, Market Access Operations, Global Rare Diseases

Alisha Angdembe

Senior Health Economist

Adrian Goretzki

President & Founder

Floortje van Nooten

Head of Market Access EU

 Nathan Chadwick

Senior Director, Therapeutic Strategy Lead – Rare Disease

Alan Minsk

Partner at Arnall Golden Gregory LLP

David Du

Sr. Manager, Market Access Operations, Global Rare Diseases

View The Full Programme

Who Should Attend

  • Rare Disease Researchers & Clinician-Scientists 
  • Biotech & Pharma R&D Executives 
  • Drug Development & Clinical Operations Leaders 
  • Market Access & Health Economics Professionals 
  • Regulators & Policy Makers 
  • Patient Advocacy Groups & Foundations 
  • Healthcare Providers & Payers

Industries Represented

  • Biopharmaceutical & Biotech Companies
  • Genomics & Advanced Therapy Developers 
  • Clinical Research Organizations (CROs) 
  • Orphan Drug Manufacturers 
  • Market Access & Health Economics Consultancies 
  • Regulatory & Health Policy Authorities 
  • Patient Organizations & Advocacy Groups

Key Themes

Rare Disease Drug Discovery & Development

  • Leveraging genomics and precision medicine for ultra-rare indications 
  • Translational research from preclinical to first-in-human studies 
  • Innovative trial designs for small patient populations

Regulatory Pathways & Orphan Designation

  • FDA, EMA, and global frameworks for orphan drug approval 
  • Expedited pathways: PRIME, Breakthrough Therapy, and Adaptive Licensing 
  • Aligning regulatory incentives with patient needs

Access, Pricing & Reimbursement

  • Health economics for high-cost therapies 
  • Innovative payment models and managed access agreements 
  • Country-level case studies in reimbursement and HTA approval

Advanced Therapeutics & Rare Diseases

  • Gene therapy, cell therapy, and RNA platforms in orphan indications 
  • Manufacturing challenges for ATMPs in small populations 
  • Long-term safety monitoring and registries

Patient-Centric Development

  • Partnering with patient advocacy groups in R&D
  • Patient-reported outcomes and quality-of-life measures 
  • Building real-world evidence through registries and digital health

Global Roadmap for Rare Disease Innovation

  • International consortia and cross-border collaborations
  • Case studies in access equity across healthcare systems 
  • Future vision for orphan drug development in a post-genomic era

Upcoming Events

Next-Wave Obesity Therapeutics & Drug…

From Discovery to Delivery: Transforming Obesity Care Through Next-Generation Therapeutics Next-Wave Obesity Therapeutics & Drug Development Summit Europe Turning breakthrough...

Read More

Multi-Omics Drug Discovery & Development…

Transforming Drug Development with Deep Multi-Omics Insights Multi-Omics Drug Discovery & Development Conference From Data Layers to Therapeutic Breakthroughs Speak,...

Read More

Advanced Therapy Medicinal Products Conference

Shaping the Future of Regenerative Medicine and Advanced Therapeutics Advanced Therapy Medicinal Products Conference Engineering the Future of Medicine —...

Read More

AI Law & Ethics Summit…

From Regulation to Responsibility: Building Trust in the Age of AI AI Law & Ethics Summit Europe 2026 Shaping a...

Read More

Targeted Protein Degradation Barcelona Summit…

Join global leaders in TPD, degrader development, and E3 ligase biology for two days of insight, innovation, and partnering. Targeted...

Read More

Reinsurance Barcelona Summit 2026

Reinsurance Barcelona Summit 2026 Welcome to the Reinsurance Barcelona Summit 2026 The Reinsurance Barcelona Summit is a premier international gathering of...

Read More

Next-Wave Obesity Therapeutics & Drug…

From Discovery to Delivery: Transforming Obesity Care Through Next-Generation Therapeutics Next-Wave Obesity Therapeutics & Drug Development Summit Europe Turning breakthrough...

Read More

Multi-Omics Drug Discovery & Development…

Transforming Drug Development with Deep Multi-Omics Insights Multi-Omics Drug Discovery & Development Conference From Data Layers to Therapeutic Breakthroughs Speak,...

Read More

Previous Events

Delegate satisfaction rate
0
Expert Speakers
0
Panel Discussions
0
Focused Driven Day
0

6 Key Themes for the Rare Diseases & Orphan Drugs Conference 2025

6 Key Themes for the Rare Diseases & Orphan Drugs Conference 2025

  1. Innovative R&D for Rare Diseases: Novel targets, trial design, and translational approaches. 
  2. Regulatory Strategy & Orphan Designation: Incentives, approvals, and cross-border harmonization. 
  3. Market Access & Reimbursement: Value frameworks, payer engagement, and affordability. 
  4. Advanced Therapeutics in Rare Indications: Gene, cell, and RNA therapies for ultra-rare diseases. 
  5. Patient-Centered Approaches: Advocacy partnerships, registries, and digital health integration. 
  6. Global Policy & Collaboration: Building sustainable, equitable systems for rare disease innovation.

The Rare Diseases & Orphan Drugs Conference 2025

Why Attend

  • Discover the latest breakthroughs in orphan drug discovery and precision medicine.
  • Network with biotech leaders, regulators, and patient advocates shaping the field. 
  • Gain practical insights into trial design, market access, and reimbursement for rare disease therapies. 
  • Explore real-world case studies in gene therapy, regulatory pathways, and patient partnerships.

Who Will Benefit

Biotech and pharma professionals, translational researchers, regulators, payers, advocacy leaders, and anyone working to bring life-changing therapies to patients with rare diseases.

The Rare Diseases & Orphan Drugs Conference 2025

Get in touch for Group Discounted Tickets

Book An Exhibition Stand + 2 Delegate Passes: Book Now For Just: 4,999 €

Discover how you can be a part of this exciting conference and get your expertise in front of your target audience. Packages Include; Exhibition Area, Main Stage Speaking, One-To-One Meetings.

Twoknct Media & Publishing we have exciting offers and news about our upcoming events that we hope you’d like to hear about! We will use your information to predict what you might be interested in. Please remember to check your junk folder for the brochure – and add info@twoknctmedia.com to your safe senders list.

Get in touch for Group Discounted Tickets

To register your team now and benefit from huge group savings, call the conference team on +420 776 164 009 (Prague office) || +44 2038 076 227 (London office)

* We hope you’d like to hear about! We will use your information to predict what you might be interested in.

Venue Details

Hotel SB Plaza Europa

Carrer de les Ciències, 11, 13, 08908 L’Hospitalet de Llobregat, Barcelona, Spain

Sponsors & Partners

Interested?

Still Thinking To Book Your Tickets? Or Know More About Our Speakers.